Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.10.1 (
ERK
)
95,504
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rho GTPases are important regulators for cell dynamics. They are activated by guanine nucleotide exchange factors and inactivated by GTPase-activating proteins (GAPs). We recently identified a novel RhoGAP,
BPGAP1
, that uses the BNIP-2 and Cdc42GAP homology (BCH) domain, RhoGAP domain and proline-rich region to regulate cell morphology and migration. To further explore its roles in intracellular signaling, we employed protein precipitations and matrix-assisted laser desorption/ionization mass-spectrometry and identified EEN/endophilin II as a novel partner of
BPGAP1
. EEN is a member of the endocytic endophilin family but its function in regulating endocytosis remains unclear. Pull-down and co-immunoprecipitation studies with deletion mutants confirmed that EEN interacted directly with
BPGAP1
via its Src homology 3 (SH3) domain binding to the proline-rich region 182-PPPRPPLP-189 of
BPGAP1
, with prolines 184 and 186 being indispensable for this interaction. Overexpression of EEN or
BPGAP1
alone induced EGF-stimulated receptor endocytosis and ERK1/2 phosphorylation. These processes were further enhanced when EEN was present together with the wildtype but not with the non-interactive proline mutant of
BPGAP1
. However, EEN lacking the SH3 domain served as a dominant negative mutant that completely inhibited these effects. Furthermore,
BPGAP1
with a catalytically inactive GAP domain also blocked the effect of EEN and/or
BPGAP1
in EGF receptor endocytosis and concomitantly reduced their level of augmentation for ERK1/2 phosphorylation. Our findings reveal a concomitant activation of endocytosis and
ERK
signaling by
BPGAP1
via the coupling of its proline-rich region, which targets EEN and its functional GAP domain.
BPGAP1
could therefore provide an important link between cytoskeletal network, endocytic trafficking and Ras/MAPK signaling.
...
PMID:Activation of EGF receptor endocytosis and ERK1/2 signaling by BPGAP1 requires direct interaction with EEN/endophilin II and a functional RhoGAP domain. 1594 98
BPGAP1
is a Rho GTPase-activating protein (RhoGAP) that regulates cell morphogenesis, cell migration, and
ERK
signaling by the concerted action of its proline-rich region (PRR), RhoGAP domain, and the BNIP-2 and Cdc42GAP homology (BCH) domain. Although multiple cellular targets for the PRR and RhoGAP have been identified, and their functions delineated, the mechanism by which the BCH domain regulates functions of
BPGAP1
remains unclear. Here we show that its BCH domain induced robust
ERK
activation leading to PC12 cell differentiation by targeting specifically to K-Ras. Such stimulatory effect was inhibited, however, by both dominant-negative mutants of Mek2 (Mek2-K101A) and K-Ras (K-Ras-S17N) and also by the small G-protein GDP dissociation stimulator (SmgGDS). Consequently SmgGDS knockdown released this inhibition and resulted in a superinduction of K-Ras activation and PC12 differentiation mediated by BCH domain. These results demonstrate the versatility of the BCH domain of
BPGAP1
in regulating
ERK
signaling by involving K-Ras and SmgGDS and support the unique role of
BPGAP1
as a dual regulator for Ras and Rho signaling in cell morphogenesis and differentiation.
...
PMID:SmgGDS antagonizes BPGAP1-induced Ras/ERK activation and neuritogenesis in PC12 cell differentiation. 2315 2
Simultaneous hyperactivation of stress-activated protein kinase/c-Jun N-terminal protein kinase (SAPK/JNK) and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/
ERK
) signaling cascades has been reported in carcinogenesis. However, how they are integrated to promote oncogenesis remains unknown. By analyzing breast invasive carcinoma database (The Cancer Genome Altas), we found that the mRNA expression levels of both JNK1 and ERK2 are positively correlated with the mRNA level of EEA1, an endosome associated protein, indicating the potential JNK/
ERK
crosstalk at endosome. Unbiased screen of different endosome-associated Rab GTPases reveals that late endosome serves as a unique platform to integrate JNK/
ERK
signaling. Furthermore, we identify that
BPGAP1
(a BCH domain-containing, Cdc42GAP-like Rho GTPase-activating protein) promotes MEK partner 1 (MP1)-induced
ERK
activation on late endosome through scaffolding MP1/MEK1 complex. This regulatory function requires phosphorylation of
BPGAP1
by JNK at its C terminal tail (Ser424) to unlock its autoinhibitory conformation. Consequently, phosphorylated
BPGAP1
facilitates endosomal
ERK
signaling transduction to the nucleus, driving cell proliferation and transformation via the
ERK
-Myc-CyclinA axis.
BPGAP1
therefore provides a crucial spatiotemporal checkpoint where JNK and MP1/MEK1 work in concert to regulate endosomal and nuclear
ERK
signaling in cell proliferation control.
...
PMID:BPGAP1 spatially integrates JNK/ERK signaling crosstalk in oncogenesis. 2809 72